Bellevue Group AG - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 101 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$328,00031,5000.01%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders